Fundies.
English

Segment disclosures

Company overview

Organovo Holdings, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 24 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Product · Mosaic Segment

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=onvo:MosaicSegmentMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2024-03-310 USD20240531Open filing evidence
2022-04-01 – 2023-03-310 USD20240531Open filing evidence

Operating Segments · Royalty · Research Development Segment

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember;us-gaap:StatementBusinessSegmentsAxis=onvo:ResearchDevelopmentSegmentMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2024-03-31109000 USD20240531Open filing evidence
2022-04-01 – 2023-03-31370000 USD20240531Open filing evidence

Operating Segments · Mosaic Segment · Product

Consolidation Items · Statement Business Segments · Product Or Service

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=onvo:MosaicSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-319000 USD20250219Open filing evidence
2024-04-01 – 2024-12-3125000 USD20250219Open filing evidence
2024-07-01 – 2024-09-302000 USD20241108Open filing evidence
2024-04-01 – 2024-09-3016000 USD20241108Open filing evidence
2024-04-01 – 2024-06-3014000 USD20240805Open filing evidence
2023-10-01 – 2023-12-310 USD20250219Open filing evidence
2023-04-01 – 2023-12-310 USD20250219Open filing evidence
2023-07-01 – 2023-09-300 USD20241108Open filing evidence
2023-04-01 – 2023-09-300 USD20241108Open filing evidence
2023-04-01 – 2023-06-300 USD20240805Open filing evidence

Research Development Segment · Operating Segments · Royalty

Statement Business Segments · Consolidation Items · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=onvo:ResearchDevelopmentSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-3115000 USD20250219Open filing evidence
2024-04-01 – 2024-12-3168000 USD20250219Open filing evidence
2024-07-01 – 2024-09-3028000 USD20241108Open filing evidence
2024-04-01 – 2024-09-3053000 USD20241108Open filing evidence
2024-04-01 – 2024-06-3025000 USD20240805Open filing evidence
2023-10-01 – 2023-12-315000 USD20250219Open filing evidence
2023-04-01 – 2023-12-3180000 USD20250219Open filing evidence
2023-07-01 – 2023-09-300 USD20241108Open filing evidence
2023-04-01 – 2023-09-3075000 USD20241108Open filing evidence
2023-04-01 – 2023-06-3075000 USD20240805Open filing evidence